Axsome Therapeutics (AXSM) had the highest return between 2018 and 2022 by a US stock in the Pharmaceuticals Industry, returning 1,265.1%.

ASSET	YEARS	% RETURN
Axsome Therapeutics (AXSM)	2018-2022	1,265.13%
Harrow Health (HROW)	2018-2022	768.24%
ProPhase Labs (PRPH)	2018-2022	666.17%
Cassava Sciences (SAVA)	2018-2022	629.38%
Eli Lilly and (LLY)	2018-2022	376.5%
Novo Nordisk A-S (NVO)	2018-2022	175.58%
Merck (MRK)	2018-2022	140.07%
Verona Pharma PLC ADR (VRNA)	2018-2022	136.47%
AstraZeneca PLC ADR (AZN)	2018-2022	123.6%
Reviva Pharmaceuticals (RVPHW)	2018-2022	120%
Zoetis (ZTS)	2018-2022	108.35%
Pfizer (PFE)	2018-2022	78.07%
Amylyx Pharmaceuticals (AMLX)	2018-2022	75.95%
Ventyx Biosciences (VTYX)	2018-2022	75.82%
Arvinas (ARVN)	2018-2022	62.9%
SIGA Technologies (SIGA)	2018-2022	62.84%
CorMedix (CRMD)	2018-2022	62.31%
Dr Reddy’s Laboratories Ltd ADR (RDY)	2018-2022	55.27%
Novartis AG ADR (NVS)	2018-2022	48.32%
Amphastar P (AMPH)	2018-2022	45.18%
Johnson & Johnson (JNJ)	2018-2022	44.36%
Prestige Brand (PBH)	2018-2022	42.9%
Sanofi ADR (SNY)	2018-2022	37.98%
Harmony Biosciences (HRMY)	2018-2022	37.78%
Bristol-Myers Squibb (BMY)	2018-2022	36.49%